ATHERTON, Calif.–(BUSINESS WIRE)–TearOptix Secures Strategic Funding to Transform Presbyopia Treatment and Announces Creation of Scientific Advisory Board
Uncategorized
National Vision Holdings, Inc. Details Transformation Strategy and Long-Term Financial Objectives Underpinning Bold Reinvention
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will host an Investor Day at NASDAQ MarketSite in New York City today to detail its comprehensive transformation strategy and financial outl…
Drug Used for Enlarged Prostate Tied to High Glaucoma Risk
The use of alpha-blockers for benign prostatic hyperplasia is tied to an increased risk of developing acute angle-closure glaucoma, a study finds. Medscape Medical News
Uncategorized
Q&A: New milestone in osteopathic medicine shows profession is ‘hitting its stride’
The osteopathic medicine profession passed 200,000 physicians and medical students for the first time in the field’s over 150-year history, the American Osteopathic Association announced.The milestone “is a powerful testament to the growing trust patie…
Uncategorized
Real-world data show extended injection intervals with Eylea HD
ORLANDO — In this video from the American Academy of Ophthalmology meeting, Diana V. Do, MD, discusses the real-world use of aflibercept 8 mg in wet age-related macular degeneration or diabetic macular edema.A study of data from the IRIS Registry looke…
Uncategorized
‘Meaningful improvement in vision’ seen in ELARA study
ORLANDO — In this video from the American Academy of Ophthalmology meeting, Diana V. Do, MD, said aflibercept 8 mg showed vision improvement and a reduction in retinal thickness.The ELARA study evaluated frequent dosing of Eylea HD (aflibercept 8 mg, R…